Gyneco-Obstetric Ultrasound Systems - Market Insights, Competitive Landscape, and Market Forecast - 2030

Gyneco-obstetric Ultrasound Systems Market by Technology (2D, 3D, and 4D), Modality (Portable and On-Platform), End-User (Hospitals, Gynecology Clinics, and Diagnostic Centers), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to advance at a respectable CAGR forecast till 2030 owing the increasing instances of gynecological disorders and rising product developmental activities across the globe

The gyneco-obstetric ultrasound systems market was valued at USD 2.68 billion in 2023, growing at a CAGR of 5.70% during the forecast period from 2024 to 2030, in order to reach USD 3.73 billion by 2030. The gyneco-obstetric ultrasound systems market is witnessing positive growth owing to factors such as the increasing instances of gynecological disorders such as pregnancies, ovarian cysts, fibroids, polycystic ovary syndrome, endometriosis and others, advancements in technology, and the increasing demand for comprehensive reproductive health monitoring among others that are acting as major factors driving the growth of the gyneco-obstetric ultrasound systems market during the forecast period from 2024 to 2030.

Gyneco-Obstetric Ultrasound Systems Market Dynamics:

According to data from the World Health Organization 2024, each year, an estimated 21 million pregnancies occur among adolescents aged 15 to 19 years in low- and middle-income countries. Adolescent mothers, aged 10-19 years, face significantly higher risks of complications such as eclampsia, puerperal endometritis, and systemic infections compared to women aged 20-24 years. Additionally, approximately 73 million induced abortions are performed globally each year. Induced abortions account for 61% of all unintended pregnancies and 29% of all pregnancies. The same source in 2023 stated that polycystic ovary syndrome (PCOS) affects approximately 8 to 13% of women of reproductive age. Despite its prevalence, up to 70% of those affected remain undiagnosed globally. PCOS stands as the most frequent cause of anovulation and is a major contributor to infertility. Also, endometriosis impacts approximately 10% of women and girls of reproductive age worldwide, affecting an estimated 190 million individuals.

As per the latest statistics given by the U.S. Department of Health & Human Services in February 2021, by the time women reach at the age of 50, between 20 to 80 percent of women are expected to have fibroids globally.

Gyneco-obstetric ultrasound systems are indispensable for monitoring pregnancies. They help in the early detection and management of conditions like eclampsia, puerperal endometritis, and systemic infections. These are pivotal in diagnosing and monitoring conditions such as PCOS and endometriosis, by providing detailed imaging, these systems enable healthcare providers to identify ovarian cysts, fibroids, and other anomalies, facilitating timely intervention and treatment. Furthermore, gyneco-obstetric ultrasound aids in assessing the health and development of the fetus, guiding decisions regarding induced abortions, and managing other related conditions, thereby enhancing overall patient care and outcomes.

Introduction of technologically advanced products by the market key players push forward the market for gyneco-obstetric ultrasound systems. For example, in April 2024, GE HealthCare unveiled two ultrasound systems, the Voluson Signature 20 and 18, both equipped with artificial intelligence programs designed to aid in diagnosing women's health conditions, including obstetric exams. These systems featured AI tools capable of automatically identifying and annotating measurements of fetal anatomy, tasks commonly performed during second-trimester exams. Additionally, the AI software provided step-by-step guidance for assessing the structure of the fetal heart and assisted in imaging the pelvic floor, as well as mapping and classifying fibroids.

Therefore, the factors stated above collectively will drive the overall gyneco-obstetric ultrasound systems market growth.

However, side effects such as cavitation & thermal effects and the presence of alternative imaging modalities, and others may prove to be challenging factors for the gyneco-obstetric ultrasound systems market growth.

Gyneco-Obstetric Ultrasound Systems Market Segment Analysis:

Gyneco-obstetric Ultrasound Systems Market by Technology (2D, 3D, and 4D), Modality (Portable and On-Platform), End-User (Hospitals, Gynecology Clinics, and Diagnostic Centers), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the modality segment of the gyneco-obstetric ultrasound systems market, the portable category is expected to have a significant revenue share in the year 2023. This is because of the features and various advantages of portable category that enhance their utility and effectiveness.

Portable gyneco-obstetric ultrasound systems are compact, lightweight devices designed for use in various clinical settings, including clinics, emergency rooms, and remote areas. Key features include high-resolution 2D, 3D, and Doppler imaging, along with AI-driven software that automates measurements, detects anomalies, and enhances image quality. These systems enable point-of-care assessments for routine prenatal check-ups, fetal monitoring, and emergency evaluations, and they provide real-time guidance for procedures like amniocentesis. Their integration with telemedicine platforms allows remote consultations, improving access to care and enhancing diagnostic accuracy in underserved locations.

Additionally rising product developmental activities by the key market players and regulatory approvals also increase the market share for same. For example, in November 2022, Royal Philips introduced the Compact 5000 Series, a next-generation portable ultrasound solution launched at the Radiological Society of North America (RSNA) annual meeting. This new system aims to deliver the high diagnostic quality typically found in premium cart-based ultrasound systems, enhancing accessibility for a broader patient population.

Therefore, the features and various advantages of portable devices that enhance performance and usability, solidify the significant impact on the growth of the overall gyneco-obstetric ultrasound systems market during the forecast period from 2024 to 2030.

North America is expected to dominate the overall gyneco-obstetric ultrasound systems market:

Among all the regions, North America is expected to dominate the gyneco-obstetric ultrasound systems market in the year 2023 and is expected to do the same during the forecast period from 2024 to 2030. This growth can be attributed to the large patient population suffering from ovarian cancer, and endometriosis, increasing investments in imaging modalities, and regulatory approvals which are acting as key factors contributing to the growth of the gyneco-obstetric ultrasound systems market in the North America region during the forecast period.

Data from the Global Cancer Observatory 2024, stated that in 2022, 0.0245 million were affected by ovarian cancer, and by 2045, 0.0315 million are projected to be diagnosed with ovarian cancer in the region.

According to the American Cancer Society 2023, around 19,710 new cases of ovarian cancer were diagnosed in 2023 in the US. According to data from the Journal of Obstetrics and Gynecology Canada (2020), in a survey conducted from 2018-2019, the estimated prevalence of endometriosis was found to be 7%, out of which 84.1% of the women were aged between 18 and 29.

Gyneco-obstetric ultrasound systems play a crucial role in the management and diagnosis of ovarian cancer and endometriosis. For ovarian cancer, these systems are essential for detecting tumors, monitoring their progression, and guiding treatment decisions. They provide high-resolution imaging that helps in identifying abnormal growths and assessing their size and location. In the case of endometriosis, ultrasound systems are used to visualize the presence and extent of endometrial tissue outside the uterus, which aids in accurate diagnosis and monitoring.

Additionally, the Canadian Association of Radiologists recommended the Canadian Government to act on various issues, such as a federal investment of USD 1.5 billion over five years in medical imaging equipment and health human resources, to support the increased capacity. The Association further recommended the creation of a National Data Science Institute to harness AI for the strategic prioritization of health human resources, technology, and infrastructure for medical imaging.

Moreover, in June 2024, Clarius Mobile Health, a leading provider of high-definition handheld ultrasound systems, obtained FDA clearance for its Clarius OB AI fetal biometric measurement tool, enhancing access to obstetrical prenatal monitoring and care in resource-limited areas. The OB AI model was designed to automatically perform fetal biometry measurements, estimating fetal age, weight, and growth intervals. This tool became available with the Clarius C3 HD3 wireless handheld ultrasound scanner in the US and Canada.

Therefore, the interplay of all the aforementioned factors would provide a conducive growth environment for the North American gyneco-obstetric ultrasound systems market.

Gyneco-Obstetric Ultrasound Systems Market key players:

Some of the key market players operating in gyneco-obstetric ultrasound systems include Koninklijke Philips N.V., Siemens Healthcare Private Limited, GE HealthCare, CANON MEDICAL SYSTEMS CORPORATION, Esaote SPA, Draminski., MedGyn Products, Inc., FUJIFILM Corporation, Intel Corporation, Xuzhou Kaixin Electronic Instrument Co., Ltd., Promed Technology Co., Limited, SIFSOF LLC., Amolab S.r.l., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., CHISON Medical Technologies Co., Ltd., SAMSUNG HEALTHCARE, SonoScape Medical Corp., and others.

Recent Developmental Activities in the Gyneco-Obstetric Ultrasound Systems Market:

• In November 2023, Siemens Healthcare Private Limited, launched ACUSON Maple, a powerful, versatile, and affordable ultrasound system designed to enable rapid diagnosis and assessment across all clinical settings. Its AI-powered features were developed to enhance everyday clinical performance, making it accessible and efficient for users of all skill levels.
• In February 2023, SAMSUNG HEALTHCARE launched the HERA W10 Elite ultrasound system offering 2D and 3D visualization of microcirculatory and slow blood flow using the Advanced MV-Flow(TM) feature. It also included a large organic light-emitting diode (OLED) display, which enhanced the characterization of diverse ultrasound images.
• In June 2021, Mindray launched its latest cart-based ultrasound system and tailored solution for Obstetrics and Gynecology (OB/GYN), Nuewa I9.

Key Takeaways from the Gyneco-Obstetric Ultrasound Systems Market Report Study

• Market size analysis for current gyneco-obstetric ultrasound systems market size (2023), and market forecast for 6 years (2024 to 2030)
• Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
• Key companies dominating the gyneco-obstetric ultrasound systems market
• Various opportunities available for the other competitors in the gyneco-obstetric ultrasound systems market space.
• What are the top-performing segments in 2023? How these segments will perform in 2030?
• Which are the top-performing regions and countries in the current gyneco-obstetric ultrasound systems market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for gyneco-obstetric ultrasound systems market growth in the coming future?

Target Audience who can be benefited from this Gyneco-Obstetric Ultrasound Systems Market Report Study

• Gyneco-obstetric ultrasound systems product providers
• Research organizations and consulting companies
• Gyneco-obstetric ultrasound systems-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and traders dealing in gyneco-obstetric ultrasound systems
• Various end-users who want to know more about the gyneco-obstetric ultrasound systems market and the latest technological developments in the gyneco-obstetric ultrasound systems market

Frequently Asked Questions for the Gyneco-Obstetric Ultrasound Systems Market:

1. What are Gyneco-Obstetric Ultrasound Systems?

The gyneco-obstetric ultrasound systems are specialized medical imaging devices designed to assess and monitor the reproductive and fetal health of patients. These systems play a crucial role in gynecology and obstetrics by providing real-time images of the female pelvic organs, including the uterus, ovaries, and developing foetus.

2. What is the market for Gyneco-Obstetric Ultrasound Systems?

The gyneco-obstetric ultrasound systems market was valued at USD 2.68 billion in 2023, growing at a CAGR of 5.70% during the forecast period from 2024 to 2030, to reach USD 3.73 billion by 2030.

3. What are the drivers for the Gyneco-Obstetric Ultrasound Systems market?

The gyneco-obstetric ultrasound systems market is witnessing positive growth owing to factors such as the increasing instances of gynecological disorders such as pregnancies, ovarian cysts, fibroids, polycystic ovary syndrome, endometriosis and others, advancements in technology, and the increasing demand for comprehensive reproductive health monitoring among others are acting as major factors that are expected to propel the growth of the gyneco-obstetric ultrasound systems market during the forecast period from 2024 to 2030.

4. Who are the key players operating in the Gyneco-Obstetric Ultrasound Systems market?

Some of the key market players operating in Gyneco-Obstetric Ultrasound Systems include Koninklijke Philips N.V., Siemens Healthcare Private Limited, GE HealthCare, CANON MEDICAL SYSTEMS CORPORATION, Esaote SPA, Draminski., MedGyn Products, Inc., FUJIFILM Corporation, Intel Corporation, Xuzhou Kaixin Electronic Instrument Co., Ltd., Promed Technology Co., Limited, SIFSOF LLC., Amolab S.r.l., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., CHISON Medical Technologies Co., Ltd., SAMSUNG HEALTHCARE, SonoScape Medical Corp., and others.

5. Which region has the highest share in the Gyneco-Obstetric Ultrasound Systems market?

North America is expected to dominate the overall gyneco-obstetric ultrasound systems market during the forecast period from 2024 to 2030. This growth can be attributed to the large patient population suffering from ovarian cancer, and endometriosis, increasing investments in imaging modalities, and regulatory approvals which are acting as key factors contributing to the growth of the gyneco-obstetric ultrasound systems market in the North America region during the forecast period.